1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Veterinary Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Veterinary Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Veterinary Vaccines Market Regional Analysis
6.2 North America Veterinary Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 North America Veterinary Vaccines Market Forecast Analysis
7. North America Veterinary Vaccines Market Analysis – by Vaccine Type
7.1 Livestock Vaccines
- 7.1.1 Overview
- 7.1.2 Livestock Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Companion Animal Vaccines
- 7.2.1 Overview
- 7.2.2 Companion Animal Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. North America Veterinary Vaccines Market Analysis – by Technology
8.1 Live Attenuated Vaccines
- 8.1.1 Overview
- 8.1.2 Live Attenuated Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Inactivated Vaccines
- 8.2.1 Overview
- 8.2.2 Inactivated Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Toxoid Vaccines
- 8.3.1 Overview
- 8.3.2 Toxoid Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Recombinant Vaccines
- 8.4.1 Overview
- 8.4.2 Recombinant Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.5 Conjugate Vaccines
- 8.5.1 Overview
- 8.5.2 Conjugate Vaccines: North America Veterinary Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. North America Veterinary Vaccines Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Veterinary Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 North America Veterinary Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 US: North America Veterinary Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.1.2 US: North America Veterinary Vaccines Market Breakdown, by Technology
- 9.2.1.2 Canada:
North America Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Canada: North America Veterinary Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.2.2 Canada: North America Veterinary Vaccines Market Breakdown, by Technology
- 9.2.1.3 Mexico :
North America Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 Mexico : North America Veterinary Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.3.2 Mexico : North America Veterinary Vaccines Market Breakdown, by Technology
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 BIOVAC
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Boehringer Ingelheim International GmbH
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Ceva
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Elanco
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 HIPRA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Merck & Co., Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 NEOGEN Corporation
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Virbac
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Zoetis Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Veterinary Vaccines Market
